Apotex Launches Pre-Emptive Strike Against Par

Law360, New York (March 15, 2006, 12:00 AM EST) -- A patent squabble has erupted between two generic drug makers, as Apotex Inc. has slapped Par Pharmaceuticals with a lawsuit in hopes of blocking the company from suing it over a generic version of appetite stimulant Megace.

Apotex filed the lawsuit in U.S. District Court for the District of New Jersey last Friday, requesting that the court issue a declaratory judgment regarding four patents held by Par.

The intellectual property covers a generic version of Megace, known as megestrol acetate oral suspension, in addition to the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.